News
- December 10, 2012
- Conclusion of Joint Sales Agreement on the overactive bladder therapeutic drug HOB-294 (oxybutynin hydrochloride transdermal therapeutic formulation)
- October 29, 2012
- Initiation of a Global Phase III Clinical Trial for ART-123
- February 13, 2012
- Initiation of Phase IIa Clinical Trial for Glaucoma Drug Candidate by Altheos, Inc.
- February 1, 2012
- Application for approval of Famvir® anti-herpes agent for additional indication
- January 10, 2012
- Launch of Flivas™ (naftopidil) in Korea